Transitional Coverage News Today

Helius Medical Technologies, Inc. beats earnings expectations. Reported EPS is $-1.47, expectations were $-4.05.

By Chris Wack Helius Medical Technologies shares were up 21% to $8.55 after the company said it has concluded its interaction with the U.S. Food and Drug...

On October 17, 2023, CMS held their quarterly National Stakeholder Call to provide updates on recent accomplishments and how their initiatives advance...

Closer collaboration between FDA and CMS is the need of the hour

As the life sciences, medtech, and diagnostic industries continue to expand and grow increasingly complex, so does the legal, regulatory, and compliance landscape. To help companies and...

The med-tech industry had high hopes in 2023 regarding Medicare coverage for breakthrough medical devices, but those hopes were dashed when the U.S. Centers for Medicare & Medicaid Services (CMS) withdrew the associated draft rule and will instead issue a “notice” regarding the Transitional Coverage for Emerging Technologies (TCET) concept.

Cutting-edge technology is desirable to consumers for its ability to deliver innovative solutions, improved efficiency, enhanced user experiences, and the promise of staying ahead in an...

Operator: Good day, everyone. My name is Chelsea, and I will be your conference operator.

PRESS RELEASE REGULATED INFORMATION - INSIDE INFORMATION 14 September 2023, 07:00 CEST alfapump® - strong pivotal POSEIDON data...

PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION14 September 2023, 07:00 CEST alfapump® – strong pivotal POSEIDON data presented at leading international liver congress / on track to file Pre-Market